Toggle light / dark theme

How Hair Cells in the Ear Actively Respond to Sound

Tiny hair cells located in the inner ear help us hear and maintain balance. On top of each hair cell is a hair bundle, a sensory organelle that converts mechanical input from sound or movement into electrical output, which is then passed on to the brain. Previous research has shown that hair bundles aren’t simply passive entities. They actively oscillate to amplify weak audio signals or to tune into specific frequencies. Biologists have also observed bundles oscillating in the absence of stimuli. Models have tried to capture this bundle behavior, but the connection between active oscillation and the audio response has not been made clear. A new thermodynamic model of energy flow within hair bundles suggests that they work like tiny machines [1]. Depending on the stimulus, the bundles either extract power from incoming sound waves or inject power into them—corresponding, respectively, to sensing or amplifying a stimulus.

In the inner ear, an active process called cochlear amplification helps humans (and other mammals) hear the faintest of sounds. When a faint whisper enters the ear, for example, the outer rows of hair cells respond to the weak signal by moving in a way that amplifies the sound waves for the inner hair cells, which are the ones that send a message to the brain. Molecular motors propel the movement or twisting of hair bundles required for these functions.

Previous work has explored how much energy a hair cell consumes to drive bundle oscillations, but the resulting models have typically assumed that bundles are moving spontaneously—that is, in the absence of external stimuli. Roman Belousov from the European Molecular Biology Laboratory in Germany and his colleagues have developed a stochastic thermodynamic model that includes an energy input from sound waves. “Instead of just looking at how a hair bundle moves on its own, we wanted to add what happens when it interacts with sound,” Belousov says.

What builds cohesion in diverse societies? Brain scans point to shared national identity cues

The brain? It has a flexible social perception. In interactions with people from different ethnic groups, it tends to respond more inclusively when a shared national identity is made salient. A study, by the University of Trento, Italy, and Nanyang Technological University, Singapore (NTU Singapore), published in Proceedings of the National Academy of Sciences, sheds light on the underlying neural mechanisms.

The findings help to better understand the relationship between ethnic and national identity and have implications for improving intergroup relations in multicultural societies.

The study shows that the brain’s representation of social boundaries can rapidly reorganize in response to context. The research team suggests that this neural flexibility underlies the human ability to navigate complex social environments characterized by multiple and interconnected group identities.

A Startup Has Been Quietly Pitching Cloned Human Bodies to Transfer Your Brain Into

That hasn’t stopped some from exploring the idea as part of a secretive effort to realize an alternative to anti-aging tech that sounds like it was ripped straight out of a dystopian science fiction novel. A billionaire-backed stealth startup, called R3 Bio, recently announced that it was raising money to develop non-sentient monkey “organ sacks,” as Wired reported last week, an eyebrow-raising alternative to animal testing. Such structures would contain all typical organs excluding the brain, ultimately serving as a source for donor organs and tissues.

But according to a sprawling followup investigation by MIT Technology Review, R3 Bio’s founders secretly have a far more ambitious goal in mind: creating entire “brainless clones” of the human body that aging or ill individuals could one day transplant their brain into. One advantage of not developing the brain in the donor bodies, albeit a ghoulish one: such a brain-free clone would neatly circumvent certain moral conundrums over the concept.

Still, to call the idea ethically fraught would be a vast understatement. Despite an insider likening a pitch they heard from R3’s founder, John Schloendorn, to a “close encounter of the third kind” with “Dr. Strangelove” in an interview with Tech Review, the company has since distanced itself from the idea of brainless human clones.

Epigenetic and transcriptomic impacts of ethanol vary by brain region and extent of exposure

New in eNeuro from Periandri et al: Systematically comparing brain markers affected by brief versus long-term exposure to alcohol in mice unveils shared and different mechanisms that may inform alcohol use disorder treatment development.

▶️


Epigenetic and transcriptional mechanisms are key contributors to alcohol use disorder (AUD). However, a better understanding of the specific genes, transcripts, and chromatin marks affected is necessary to inform novel pharmacotherapies. Here, we systematically investigate the genome-wide epigenetic and transcriptomic effects of ethanol across key brain regions relevant to AUD and assess how these outcomes differ between acute and chronic exposure in male C57BL/6J mice. We show that alcohol-derived acetate contributes to histone acetylation in the brain in response to acute or chronic exposure, with a broader and more robust effect following repeated exposure. Further, we find that chromatin and transcriptomic changes elicited by acute or chronic ethanol exposure are predominantly specific to brain region, and observe more robust dysregulation of gene and transcript expression following acute exposure. We show that ethanol-induced transcriptional changes are paradigm-dependent in some brain regions, most strikingly in the ventral hippocampus. Overall, our results systematically illuminate and compare key epigenetic and transcriptomic outcomes linked to acute and chronic ethanol exposure, which will guide the development of future therapeutic interventions.

Significance Statement This is the first study to systematically investigate epigenetic and transcriptomic changes following acute or chronic exposure to alcohol, focusing on key regions previously linked to substance use disorders. We show the molecular impact of alcohol varies among brain regions and in part depends on the extent of alcohol exposure. Our results provide unprecedented detail on how alcohol affects transcriptional regulation in the brain, which in turn will inform the development of needed novel therapeutic interventions for alcohol use disorder.

How “mindreading” AI detects hidden suicidal thoughts in the brains of young adults

A recent study published in Human Brain Mapping provides evidence that young adults experiencing suicidal thoughts process concepts related to death differently in their brains compared to healthy individuals. The findings indicate that these individuals reflexively associate death-related ideas with their own sense of self. This research suggests that brain imaging combined with artificial intelligence could eventually help identify people at risk for suicide based on how their brains represent specific words.

If you or someone you know is experiencing suicidal thoughts or a mental health crisis, help is available. Call or text 988 to reach the free and confidential Suicide & Crisis Lifeline, or chat live at 988lifeline.org.

While mental health professionals typically rely on patients to report their feelings, people at risk for suicide do not always disclose their struggles. Finding an objective physical measurement in the brain could help identify those in need of support.

Depression is linked to a genuine pessimistic bias rather than a realistic view of the world

A recent study published in the journal Behaviour Research and Therapy provides evidence that people experiencing symptoms of depression hold genuinely pessimistic biases about future positive events, rather than simply viewing the world more realistically. The research suggests that while individuals with depression can update their beliefs when desirable things happen, these hopeful shifts tend to be fragile and easily reversed.

The study was designed to test whether the negative thinking patterns seen in depression reflect a genuine bias or just an absence of normal optimism. For decades, experts have debated the idea of depressive realism, a concept suggesting that depressed individuals actually see the world more accurately than healthy individuals, who tend to be overly optimistic. To test this, the researchers wanted to see how people predict everyday life events and how they adjust those expectations when real life proves them wrong.

“We know that depression involves a generally pessimistic outlook on life. Previous research has shown that people with high depressive symptoms tend to underestimate the likelihood of positive outcomes in their lives,” said study author Joe Maffly-Kipp, a postdoctoral fellow in the Mood & Individual Differences Lab (MIND Lab) at The Ohio State University Wexner Medical Center.

Study of 6 Million People Could Rewrite How We Understand Mental Health

From the article:

The study also identified specific brain cell types associated with the genetic patterns.

For the schizophrenia bipolar group, the strongest genetic signals appeared in genes active in excitatory neurons. These neurons transmit signals that activate other brain cells and help different parts of the brain communicate.

In contrast, genetic risk tied to internalizing disorders such as depression, anxiety, and PTSD showed stronger links to oligodendrocytes. These cells help nerve signals travel more efficiently through the brain.

“The findings suggest these ‘support cells’ might play an important role in those conditions,” said Verhulst, research assistant professor and an expert in quantitative and statistical genetics.”


A massive genetic analysis of more than 6 million people is revealing new clues about why mental health disorders frequently overlap.

Pitfalls and Potential of Dementia Prevention Trials

💬 Editorial by Holly Elser, MD, PhD, and Jonathan Graff-Radford, MD:

Recent randomized clinical trials on dementia prevention highlight several challenges in interpreting lifestyle intervention studies, including practice and Hawthorne effects, modest changes in cognitive outcomes, and heterogeneity in both trial design and participant baseline risk.

The trial by Zhang et al—evaluating aerobic exercise and intensive vascular risk reduction—showed no significant cognitive benefit over 2 years in older adults at elevated risk, underscoring the potential influence of midlife vs late-life intervention timing and the need for longer trials or biomarker-enriched cohorts to better assess dementia prevention strategies.


Dementia prevention is a global public health priority,1,2 with up to 45% of cases potentially attributable to modifiable risk factors over the life course.3 While recent landmark trials, including FINGER, SPRINT MIND, and POINTER, suggest either single-or multidomain lifestyle interventions can improve cognitive outcomes,4-6 others have shown no clear benefit,7,8 thus highlighting ongoing uncertainty in the field.

In this issue of JAMA Neurol ogy, Zhang and colleagues9 report the results of a single-blind, multicenter randomized clinical trial of the effects of exercise and intensive vascular risk reduction on cognitive function. Eligible study participants were between the ages of 60 and 85 years at baseline with a history of hypertension, family history of dementia, or self-reported cognitive decline. The study used a 2 × 2 factorial design wherein participants were randomized to aerobic exercise training alone, intensive pharmacological reduction of cardiovascular risk factors (IRVR) alone, both aerobic exercise and IRVR, or usual care for a 24-month period. The IRVR protocol lowered systolic blood pressure to less than 130 mm Hg, and participants with baseline serum low-density lipoprotein cholesterol (LDL-C) of 70 mg/dL or higher were also treated with a high-intensity statin.

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure

Patients treated with cadaveric pituitary-derived human growth hormone contaminated with amyloid-β developed early-onset AlzheimerDisease with prominent language deficits and histopathological features consistent with AD.


Question What are the clinical and postmortem findings in iatrogenic Alzheimer disease (iAD) consequent to treatment with cadaveric pituitary–derived human growth hormone (c-hGH)?

Findings This case series describes a c-hGH recipient with early-onset dementia and prominent language involvement, in whom postmortem examination showed unequivocal neuropathological features of AD, including severe tauopathy. Three additional c-hGH recipients have similar cognitive syndromes characterized by prominent language involvement.

Meaning These results demonstrate that patients with iAD can have histopathological findings classically found in sporadic AD and that prominent language involvement might be an important phenotypic feature in this AD subtype.

/* */